Diurnal Group plc DNL.L Stock
Diurnal Group plc Price Chart
Diurnal Group plc DNL.L Financial and Trading Overview
| Diurnal Group plc stock price | 27.3 GBP |
| Previous Close | 27.3 GBP |
| Open | 0 GBP |
| Bid | 27.1 GBP x 0 |
| Ask | 0 GBP x 0 |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 67.9 GBP |
| Volume | 88.55K GBP |
| Avg. Volume | 892.48K GBP |
| Market Cap | 47.74M GBP |
| Beta (5Y Monthly) | 0.353444 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 91.25 GBP |
DNL.L Valuation Measures
| Enterprise Value | 29.77M GBP |
| Trailing P/E | N/A |
| Forward P/E | -0.026686218 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.191456 |
| Price/Book (mrq) | 214.96062 |
| Enterprise Value/Revenue | 6.355 |
| Enterprise Value/EBITDA | -1.591 |
Trading Information
Diurnal Group plc Stock Price History
| Beta (5Y Monthly) | 0.353444 |
| 52-Week Change | -54.11% |
| S&P500 52-Week Change | -19.90% |
| 52 Week High | 67.9 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 25.78 GBP |
| 200-Day Moving Average | 23.78 GBP |
DNL.L Share Statistics
| Avg. Volume (3 month) | 892.48K GBP |
| Avg. Daily Volume (10-Days) | 751.05K GBP |
| Shares Outstanding | 174.86M |
| Float | 92.8M |
| Short Ratio | N/A |
| % Held by Insiders | 7.21% |
| % Held by Institutions | 78.99% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | June 30, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -399.61% |
| Gross Margin | 78.16% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.21% |
| Return on Equity (ttm) | -56.084% |
Income Statement
| Revenue (ttm) | 4.68M GBP |
| Revenue Per Share (ttm) | 0.03 GBP |
| Quarterly Revenue Growth (yoy) | -18.89% |
| Gross Profit (ttm) | 3.66M GBP |
| EBITDA | -18708000 GBP |
| Net Income Avi to Common (ttm) | -16570000 GBP |
| Diluted EPS (ttm) | -8.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.49M GBP |
| Total Cash Per Share (mrq) | 0.1 GBP |
| Total Debt (mrq) | 0 GBP |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.234 |
| Book Value Per Share (mrq) | 0.127 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18786000 GBP |
| Levered Free Cash Flow (ttm) | -13883625 GBP |
Profile of Diurnal Group plc
| Country | United Kingdom |
| State | N/A |
| City | Cardiff |
| Address | Cardiff MediCentre |
| ZIP | CF14 4UJ |
| Phone | 44 29 2068 2069 |
| Website | https://www.diurnal.co.uk |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers an oral formulation of hydrocortisone granules in capsules for the treatment of pediatric adrenal insufficiency. It also develops Chronocort, which completed Phase II clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early-stage pipeline products comprise Ditest, a native oral testosterone product, which has completed phase I clinical trial for the treatment of classical hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (triiodothyronine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.
Q&A For Diurnal Group plc Stock
What is a current DNL.L stock price?
Diurnal Group plc DNL.L stock price today per share is 27.3 GBP.
How to purchase Diurnal Group plc stock?
You can buy DNL.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diurnal Group plc?
The stock symbol or ticker of Diurnal Group plc is DNL.L.
Which industry does the Diurnal Group plc company belong to?
The Diurnal Group plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Diurnal Group plc have in circulation?
The max supply of Diurnal Group plc shares is 1.75M.
What is Diurnal Group plc Price to Earnings Ratio (PE Ratio)?
Diurnal Group plc PE Ratio is 0.00000000 now.
What was Diurnal Group plc earnings per share over the trailing 12 months (TTM)?
Diurnal Group plc EPS is 0 GBP over the trailing 12 months.
Which sector does the Diurnal Group plc company belong to?
The Diurnal Group plc sector is Healthcare.